• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals REGN 2 Star

Last Price$263.66Day Change (%)-1.24%
Open Price$265.79Day Change ($)-3.31
Day Range263.49–269.7852-Week Range107.31–283.99

As of Mon 05/20/2013 04:19 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation

    Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation

  2. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

    Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

  3. Regeneron Pharmaceuticals REGN Q4 2012 Earnings Call Transcript

    Good morning, ladies and gentlemen. Welcome to the Regeneron Pharmaceuticals' Conference Call to discuss the Fourth Quarter and Year End 2012 Financial Results. My name is Bethany, and I'll be your coordinator today. At this time all participants are in a listen-only mode. We will conduct a ...

  4. Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs

    Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs

  5. Regeneron Reports First Quarter 2013 Financial and Operating Results

    Regeneron Reports First Quarter 2013 Financial and Operating Results

  6. BioMed Realty Trust Reports First Quarter 2013 Financial Results

    BioMed Realty Trust Reports First Quarter 2013 Financial Results

  7. Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600

    Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600

  8. U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

    U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

  9. Regeneron to Join S&P 500 After MetroPCS Merger with T-Mobile

    Regeneron to Join S&P 500 After MetroPCS Merger with T-Mobile

  10. Aberdeen to Buy Artio Global Investors

    As part of Aberdeen's acquisition of Artio, some international fund managers to depart. Also, a management change on a T. Rowe Price health-care fund, Columbia hires Putnam's former asset-allocation head, and ClearBridge and Legg Mason Capital Management funds to merge.

12
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.